Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease

NCT03295786 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Herantis Pharma Plc.

Collaborators